#91Official Top 100

GSK (Tianjin)

中美天津史克制药有限公司

#91

Multinational pharmaceutical operations in ChinaVaccines and blood productsInhalation productsOTC and consumer health

Manufacturing profile

Multinational pharmaceutical operations in China
Vaccines and blood products
Inhalation products
OTC and consumer health

Selection basis

The company is included in the official 2024 ranking of the 100 largest Chinese pharmaceutical-industry enterprises by main-business revenue.

The FUZKK fit shows potential applicability of existing utilities. It does not claim actual use of FUZKK, specific installed equipment models or a product not confirmed by the public company profile.

Representative manufacturing and QC chain

  1. 1Raw-material receipt and identification
  2. 2Dispensing, blending and granulation
  3. 3Tableting, encapsulation or solution preparation
  4. 4Packaging and labelling
  5. 5HPLC, GC, KF, ICP/AAS, dissolution and stability QC
  6. 6Biological inputs or plasma pooling
  7. 7Purification and viral-clearance stages
  8. 8Formulation and adjuvant/protein control
  9. 9Sterile filling or lyophilisation

Relevant FUZKK packages

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand the scope.

Mapping boundary

The FUZKK fit shows potential applicability of existing utilities. It does not claim actual use of FUZKK, specific installed equipment models or a product not confirmed by the public company profile.

Methodology